Skip to main content
SRPT logo
SRPT
(NASDAQ)
Sarepta Therapeutics, Inc.
$17.12-- (--)
Loading... - Market loading

Sarepta Therapeutics (SRPT) Stock Price & Financial Analysis

Sarepta Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$16.58 - $17.26
52-Week High$44.14
52-Week Low$10.42
Open$16.79
Volume2.23M
Average Volume (3M)2.86M
Market Cap1.74B
Shares Outstanding104.79M
Price to Sales (P/S)0.79
Price to Book (P/B)1.53
EV/EBITDA-3.96
Revenue (TTM)2.20B
Net Income (TTM)-713.41M
Free Cash Flow (TTM)-317.43M
EPS (TTM)$-6.98
Profit Margin-32.45%
Operating Margin-31.83%
Return on Equity (ROE)-62.55%
Debt to Equity0.91
50-Day MA$19.96
200-Day MA$19.93
52-Week Change-46.66%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Sarepta Therapeutics

What is the current stock price for SRPT?

As of the latest trading session, SRPT stock trades at $17.12. The 52-week range is $10.42–$44.14, with a day range of $16.57–$17.26.

What is the P/E ratio for SRPT?

The P/E ratio (Price-to-Earnings) for SRPT is shown in the Key Statistics section. This valuation metric helps compare Sarepta Therapeutics, Inc. to industry peers.

Does SRPT pay dividends?

Sarepta Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for SRPT?

Based on 6 analysts, the consensus for SRPT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of SRPT?

Sarepta Therapeutics's market capitalization is $1.79B, classifying it as a small-cap company..